{
  "docId": "019de076-2ada-7117-9358-036add78e997",
  "docSlug": "d07954bb4369650f4386921d5f3a9e2d",
  "documentTitle": "Dare Bioscience | Results Presentation Deck | 14 slides",
  "authorId": "dare-bioscience",
  "authorName": "Daré Bioscience",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 14,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a bulleted list to outline upcoming events for XACIATO, Ovaprene, Sildenafil Cream, and DARE-PDM1.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-2ada-7117-9358-036add78e997/9",
  "deckHref": "/decks/019de076-2ada-7117-9358-036add78e997",
  "deckJsonHref": "/decks/019de076-2ada-7117-9358-036add78e997.json",
  "deckAnchorHref": "/decks/019de076-2ada-7117-9358-036add78e997#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.28,
        "w": 0.82,
        "x": 0.11,
        "y": 0.26
      },
      "kind": "list",
      "text": "XACIATO™: Receipt of $1.8 million triggered by achievement of first commercial milestone under license agreement with Organon.\nOvaprene®: Commencement of pivotal Phase 3 contraceptive efficacy study.\nSildenafil Cream, 3.6%: End-of-Phase 2 meeting with FDA.\nDARE-PDM1: Phase 1 clinical study topline data.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9b43035-487d-42ba-8adc-167402e9d0b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.02,
        "y": 0.93
      },
      "kind": "subtitle",
      "text": "* Anticipated timing",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20d4f524-b790-4497-a5d1-349f55d56caf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.54,
        "x": 0.23,
        "y": 0.03
      },
      "kind": "title",
      "text": "What to Expect for Remainder of 2023*",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b030105-0e5d-4089-8534-aa36a739480b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}